K022690 is an FDA 510(k) clearance for the PAROS CRP. Classified as System, Test, C-reactive Protein (product code DCN), Class II - Special Controls.
Submitted by Horiba, Ltd. (Irvine, US). The FDA issued a Cleared decision on December 23, 2002 after a review of 132 days - within the typical 510(k) review window.
This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5270 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.